Picture of Psychemedics logo

PMD Psychemedics Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMicro CapContrarian

Momentum

Relative Strength (%)
1m-6.88%
3m+3.18%
6m-34.66%
1yr-58.07%
Volume Change (%)
10d/3m-22.74%
Price vs... (%)
52w High-53.78%
50d MA-2.3%
200d MA-15.48%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-33.35%
Return on Equity-40.7%
Operating Margin-12.75%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Psychemedics EPS forecast chart

Profile Summary

Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and webinars. It markets its home drug testing service, PDT-90, through the Internet.

Directors

Last Annual
December 31st, 2022
Last Interim
September 30th, 2023
Incorporated
September 24th, 1986
Public Since
January 22nd, 1987
No. of Shareholders
157
No. of Employees
133
Sector
Healthcare Providers & Services
Industry
Healthcare
Exchange
us flag iconNASDAQ Capital Market
Shares in Issue
5,801,761

PMD Share Price Performance

Upcoming Events for PMD

Q4 2023 Psychemedics Corp Earnings Release

Q1 2024 Psychemedics Corp Earnings Release

Q2 2024 Psychemedics Corp Earnings Release

Psychemedics Corp Annual Shareholders Meeting

Similar to PMD

Picture of ADVANCED BIOMED logo

ADVANCED BIOMED

us flag iconNASDAQ Capital Market

Picture of American Oncology Network logo

American Oncology Network

us flag iconNASDAQ Capital Market

Picture of Assure Holdings logo

Assure Holdings

us flag iconNASDAQ Capital Market

Picture of Astrana Health logo

Astrana Health

us flag iconNASDAQ Capital Market

FAQ